[Oral therapy of type II diabetes].
Haupt
E
E
Schöffling
K
K
D001645:Biguanides / Q000627:therapeutic use; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D013453:Sulfonylurea Compounds / Q000627:therapeutic use
D001645:Biguanides; D007004:Hypoglycemic Agents; D013453:Sulfonylurea Compounds
Orale Therapie des Typ-II-Diabetes.